Benzinga's Top Pre-Market Losers
Riverbed Technology (NASDAQ: RVBD) dipped 17.46% to $14.47 in the pre-market session after the company reported downbeat second-quarter revenue.
Optimer Pharmaceuticals (NASDAQ: OPTR) shares fell 6.47% to $12.43 in the pre-market trading after Cubist Pharmaceuticals (NASDAQ: CBST) announced its plans to acquire Trius Therapeutics (NASDAQ: TSRX) and Optimer for up to $1.62 billion.
BioCryst Pharmaceuticals (NASDAQ: BCRX) shares dropped 5.78% to $3.75 in pre-market trading after the company announced its plans to sell up to $20 million in common stock.
Genworth Financial (NYSE: GNW) dipped 3.82% to $12.85 in the pre-market session after the company reported weaker-than-expected second-quarter results.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.